Lifehealthcare Group Ltd reports: Is it time to buy this recent IPO?

A prospectus-beating report could be just the beginning for Lifehealthcare Group Ltd (ASX:LHC).

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Having risen only 9.6% since its launch – unusual for a 2013 IPO – Lifehealthcare Group Ltd's (ASX: LHC) results today show there might be something to get excited about.

Better market penetration and a wider range of products on offer also look likely to generate further growth in the future once the usual costs associated with an IPO are left behind.

Highlights:

  • Sales revenue rose 13.4% to $87.2 million
  • Underlying EBITDA rose 8% to $15.3 million
  • Net Profit After Tax rose 7.5% to $7.2 million
  • Net debt down to $20.3 million (from $24 million at 30 June last year)
  • Final dividend of 7.5 cents per share
  • Targeting further market expansion in three main channels; Spine/Neurosurgery, Orthopaedics, and Cardiology
  • 12-month hedging program and 7-month inventory stocks allow significant protection from currency risks

So What?

According to management, profit growth lagged revenue as a result of increased sales of low-margin 'capital equipment' and introductory price offers for new products that have now returned to normal levels.

Lifehealthcare's strategy going forwards will be to further advertise its presence in the market and use its highly trained sales staff to generate sales to key specialists in each of the three channels.

Ideally initial sales will lead to follow-up orders in the future, and much of this depends on the quality of Lifehealthcare's product, its sales staff, and its supply chain.

Investors should bear in mind that Lifehealthcare is essentially a sales company, and management admits that its future success depends 'to a significant extent on the performance and expertise of key staff' and the ability to retain them.

Efficient administration, ordering systems and customer support will help both with staff and customer retention and a continued focus on these factors will be valuable, particularly as total sales grow.

Now What?

The annual report was short on details regarding future developments and results, noting that the company was presently focussed on consolidating its operations to ensure an effective operating model.

This is normal following an IPO, and management does note that it expects a reasonable year-on-year increase in its results for FY2015.

With an unhealthy, ageing population, Australian demand for medical services is expected to grow significantly over the next decade or more, and Lifehealthcare investors should enjoy steadily rising sales even before the company's plans for expansion.

With its current modest valuation – not even 10% above its IPO price – Lifehealthcare represents a value purchase for the long-term shareholder.

Investors looking for a company with long-term tailwinds and the potential for strong, reliable earnings increases should also take a look at The Motley Fool's free report on our latest Top Stock recommendation.

Trading on a similar valuation to Lifehealthcare, this small company enjoys even more rapid growth without the handicaps of post-IPO expenses and consolidation.

If this sounds like the kind of share you're looking for, simply click on the link below and enter your email address – it takes less than 30 seconds – and we'll send it to you, completely FREE!

Motley Fool contributor Sean O'Neill owns shares in Lifehealthcare.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »